Devonian Health Group Inc.
DVHGF
$0.07
-$0.11-60.50%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.08M | 16.81M | 23.29M | 22.11M | 17.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.08M | 16.81M | 23.29M | 22.11M | 17.64M |
| Cost of Revenue | 8.04M | 10.70M | 14.85M | 14.42M | 11.16M |
| Gross Profit | 5.04M | 6.11M | 8.44M | 7.69M | 6.48M |
| SG&A Expenses | 4.85M | 5.15M | 6.11M | 5.77M | 5.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 91.50K | 90.90K | 89.60K | 89.60K | 89.90K |
| Total Operating Expenses | 14.38M | 17.37M | 22.49M | 21.50M | 18.05M |
| Operating Income | -1.30M | -568.80K | 795.20K | 606.70K | -410.60K |
| Income Before Tax | -4.64M | -3.96M | -2.71M | 395.80K | -647.90K |
| Income Tax Expenses | 298.30K | 298.30K | 728.10K | 928.10K | 620.60K |
| Earnings from Continuing Operations | -4.94 | -4.26 | -3.44 | -0.53 | -1.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.94M | -4.26M | -3.44M | -532.30K | -1.27M |
| EBIT | -1.30M | -568.80K | 795.20K | 606.70K | -410.60K |
| EBITDA | -1.06M | -289.40K | 1.04M | 866.50K | -134.60K |
| EPS Basic | -0.03 | -0.03 | -0.02 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.03 | -0.03 | -0.02 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 610.48M | 592.89M | 592.90M | 592.22M | 590.34M |
| Average Diluted Shares Outstanding | 622.37M | 604.78M | 604.79M | 605.97M | 604.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |